Elemene for the treatment of lung cancer

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Rui, D ^b   Xiaoyan, C ^b   Taixiang, W ^b   Guanjian, Liu ^a  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

Antineoplastic agents, phytogenic *therapeutic use ; Lung neoplasms *drug therapy ; Phytotherapy *methods ; Sesquiterpenes *therapeutic use

Indexed keywords

ANTINEOPLASTIC AGENT; ELEMENE;

CANCER PAIN; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG SAFETY; HUMAN; LUNG CANCER; PHYSIOTHERAPY; REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 44949186551     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006054.pub2     Document Type: Review

References (46)

1. Cui 2001 GM Cui, ML Liu, YZ Shang, LH Yuan, JB Meng, RJ Zhang. Observation of effectiveness of radiotherapy and elemene emulsion for lung cancer. Chinese Journal of Coal Industry Medicine 2001;4(4):322.
2. Guo 2003 CH Guo, GM Li, SM Wen, DC Ren. The comparison of three drugs for the treatment of pleural effusion caused by lung cancer. Medical Journal West China 2003;1(4):336-7.
3. Jia 1997 Yingjie Jia, Jun Chen, Yiyu Sun, Dongling Yu, Fenghai Zhang, Jingrong Zhang. Clinical observation on elemene in complication with traditional Chinese medicine for the treatment of mid-late lung cancer. Chinese Journal of Clinical Oncology 1997;24(8):632-3.
4. Jiang 1998 YL Jiang, YH Wu, H Jin, M Cai. Clinical observation on 22 cases of mid-late lung cancer treated by elemene. Guang ming zhong yi 1998;13(2):29-30.
5. Liu 2000 JF Liu. Observation of the effectiveness of elemene combined with MVP regimen for the treatment of mid and late lung cancer. Hena Journal of Oncology 2000;13(6):434-5.
6. Lu 1996 LQ Lu, ZJ Liu, FH Chen. Discussion about the effect of elemene in the intervention therapy of lung cancer. Zhejiang Oncology 1996;2(3):185-6.
7. Qin 1998 SK Qin, J Qian, L Wang, ZM He, YQ Ma. Clinical observation of elemene combined with chemotherapy for the treatment of primary lung cancer. Prevention, Cure and Research of Tumor 1998;25(1):58- 60.
8. Qin ZQ 1997 ZQ Qin, YC Qu, YS Jia, ZJ Liu. Thorax injection of elemene combinded with bronchial artery perfusion for lung cancer patients with pleural effusion. Shiyong Zhongliuxue Zazhi 1997;12(4):184-5.
9. Tan 2002 SS Tan, YB Xue, GL Jiang. Elemene combined with EP regimen for the treatment of late non-small cell lung cancer. Zhejiang zhongxiyi jiehe za zhi 2002;12(4):215-6.
10. Wang 1998 RM Wang, S Jiang, F Jin. Radiotherapy combined with elemene for the treatment of non-small cell lung cancer. Journal Of Guiyang Medical College 1998;23(2):163-4.
11. Wang 2000 Jing Wang, Jian Hu, Min Gong, Zhimin Cai. Clinical observation on elemene combined with CE regimen for the treatment of late small cell lung cancer. Chinese Journal of Clinical Oncology 2000;27(4):312-3.
12. Wang 2002 P Wang, J Wang. Clinical observations on elemene combined with perfusion in thorax cavity for the treatment of late lung cancer with pleual effusion. Xiandai Yiyao Weisheng 2002;18(3):180-1.
13. Yu 1998 CQ Yu, JX Fan, YQ Wang, WL Zhou. Elemene in combination with microwave for the treatment of mid-late lung cancer. Qinu medical Magazine 1998;13(1):41.
14. Zhang 1997 MX Zhang. Clinical observation on the helpness of elemene for the chemotherapy of lung cancer. Anhui Medicine 1997;18(1):42.
15. Zhou 2001 a D Zhou. Randomized controlled observation on elemenecombined with VPand VP for the treatment of late non-small cell lung cancer. China Oncology ClinicalChina Oncology Clinical 2001;28(6):470-1.
16. Zhou 2001 b RY Zhou, ZW Xu. Clinical and Experimental Observations of Hydrothorax in Lung Cancer Cases Treated with Closed Drainage and Injection of Selfheal Spike Injection. Zhejiang Zhongxiyijiehe Zazhi 2001;11(1):5-8.
17. Li 1999 HJ Li, QJ Lin, AR Niu. Thorax perfusion of elemene for pleural effusion caused by lung cancer. Qingdao Medicine 1999;31(3):189.
18. Lin 1996 ST Lin, QN Qiu. Clinical observation on the effect of elemene for pleural effusion caused by lung cancer. Fujian Medical Magazine 1996;18(3):90.
19. Shen 2000 N Shen. Clinical observation on elemene emulsion for the treatment ofmid and late non-small cell lung cancer. J North China Coal Medical College 2000;2(4):392-3.
20. Wang 1997 XH Wang, JY Wang, YY Chen. Explore the administration methods on middle or late stage lung cancer of seniles. Wan nan medical college transaction 1997;16(4):383-4.
21. Guo 2006 Guo L, Shi G, Gao Z, Shen J, Xing R, Qian Z. Response to hepatocarcinoma Hca-F of mice immunized with heat shock protein 70 from elemene combo tumor cell vaccine. Cellular & Molecular Immunology 2006;3(4):291-5. [MEDLINE: 16978538].
22. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. British Medical Journal 2003;327(7414):557-60.
23. Higgins 2005 Higgins JPT, Green S, editors. Locating and selecting studies for reviews. Cochrane Handbook for Systematic Reviews of Interventions 4.2 [updated May 2005]; Section 5. The Cochrane Library, Issue 3. Chichester, UK: John Wiley & Sons, Ltd, 2005.
24. Hou 1994 Hou JS, Xu YH, C YR, Sun PT, Liu DH. Clinical study on elemene treating malignant intracranial tumors. Zhong Hua Shen Jing Wai Ke Za Zhi 1994;10(4):225-8.
25. Kraut 2000 Kraut M, Wozniak A. Clinical presentation of lung cancer. In: HarveyI Pass, JamesB Mitchell editor(s). Lung cancer: principle and practice. 2nd Edition. Philadelphia: Lippincott Williams and Wilkins, 2000:521-31.
26. Luo 1996 Luo DX. Observation on the effect of elemene. New Journal of Traditional Chinese Medicine 1996, (suppl.):94.
27. Ma 2004 Ma L, Weng YN, Xiao X. Treatment of NSCLC by traditional medicine and chemotherapy. ZhongHuaShiYongZhongXiYiZa-Zhi 2004;4(5):709.
28. Miller 1981 Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47(1):207-14.
29. Minna 2005 Minna J D. Neoplasms of the lung. In: Dennis L.Kasper, Eugene-Braunward, Anthony S.Fauci editor(s). Harrison's principles of internal medicine. 16. Vol. 1, McGraw Hill, 2005:506.
30. Moher 2001 Moher D, Schulz KF, Altman D. The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials. Journal of the American Medical Association 2001;285(15):1987-91.
31. Parkin 2001 Parkin DM. Global cancer statistics in the year 2000. Lancet Oncology 2001;2(9):533-43.
32. Port 2004 Port JL, Kent M, Korst RJ, Lee PC, Levin MA, Flieder D, Altorki NK. Surgical resection for lung cancer in the octogenarian. Chest 2004;126(3):733-8.
33. She 2006 She JJ, Wang ZM, Che XM, Pan CE. Research of beta-elemene interventional treatment on VX2 carcinoma transplanted on kidney in rabbits. Zhong Xi Yi Jie He Xue Bao 2006;4(6):611-4. [MEDLINE: 17090378].
34. SIGN 2005 SIGN (Scottish Intercollegiate Guidelines Network). Manegement of patients with lung cancer. A National Clinical Guideline. www.sign.ac.uk/pdf/sign80.pdf (accessed November 2005).
35. Slovis 2004 Slovis BS, Brigham RL. Neoplastic disease of the lung. In: CarpenterCJ, GrrigsRC, LoscalzoJ editor(s). Cecil Essentials of Medicine. 6th Edition. Saunders, 2004:206.
36. Tan 2006 Tan G, Wang ZY, Wang XG, Cheng L, Yin S. Immunotherapeutic effects of beta-elemene combined with interleukin-23 gene-modified dendritic cells on murine pancreatic carcinoma. Ai Zheng 2006;25(9):1082-6. [MEDLINE: 16965646].
37. Tao 1996 Tao SD, Wang HQ, Liu XM. Clinical observation on elemene in treating coronaljugular malignant tumor. Zhong Guo Zhong Liu Lin Chuang 1996;23(3):225-6.
38. Wang 2006 Wang Y, Fang MY. Effect of ginseng saponin, arsenic trioxide, beta-elemene combined with CTX on telomere-telomerase system in K562 cell line. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006;14(6):1089-95. [MEDLINE: 17204170].
39. Wang G 2005 Wang G, Li X, Huang F, Zhao J, Ding H, Cunningham C, Coad JE, Flynn DC, Reed E, Li QQ. Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cellular and Molecular Life Sciences 2005;62(7-8):881-93. [MEDLINE: 15868411].
40. Wang K 2005 Wang K, Li Z, Chen YR, Wu XY, Li SY, Su CY. Excretion of beta-elemene from rat respiratory tracts. Yao Xue Xue Bao 2005;40(1):54-6.
41. Wang Y 2005 Wang Y, Deng Y, Mao S, Jin S, Wang J, Bi D. Characterization and body distribution of beta-elemene solid lipid nanoparticles (SLN). Drug Development and Industrial Pharmacy 2005;31(8):769- 78. [MEDLINE: 16221611].
42. Wu 2007 Wu TX, Liu GJ. The concepts, design, practice and report of allocation concealment and blinding. Chinese Journal of Evidence-Based Medicine 2007;7(3):219-22.
43. Xu 2004 Xu YH, Dong B. The research development of antitumor activity of elemene. Chinese Research Journal of Practical Medicine 2004;3(2):137-9.
44. Xu 2006 Xu L, Tao S, Wang X, Yu Z, Wang M, Chen D, et al.The synthesis and anti-proliferative effects of beta-elemene derivatives with mTOR inhibition activity. Bioorganic & Medicinal Chemistry 2006;14(15):5351-6. [MEDLINE: 16617020].
45. Yang 1996 Yang H, Wang X, Yu L. The antitumor activity of elemene is associated with apoptosis. Zhonghua Zhong Liu Za Zhi 1996;18(3):169-72. [MEDLINE: 9387246].
46. Zhang 2007 Zhang HY, Hu CX, Liu CP, Li HF, Wang JS, Yuan KL, Tang JW, Xu GW. Screening and analysis of bioactive compounds in traditional Chinese medicines using cell extract and gas chromatography-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2007;43(1):151- 7. [MEDLINE: 16876368].